Prof. Dr. Md. Moklesur Rahman Sarker

PhD (Japan), M. Pharm. (JU)

Professor & Head, Academic and Research Affairs (View Profile)

Prof. Dr. Md. Moklesur Rahman Sarker is currently working as a Professor and Head of Academic & Research Affairs in the Department of Pharmacy, State University of Bangladesh. Prior to this, he served as the Director of Institutional Quality Assurance Cell of State University (a program of Higher Education Quality Enhancement Project of the University Grants Commission of Bangladesh). He is serving as the Head of Institutional Animal Ethics Committee and Executive Member of Human Ethics Committee of the State University of Bangladesh. Prof. Moklesur obtained PhD in Pharmaceutical Sciences from Okayama University (Japan) and Bachelor and Master of Pharmacy degrees from Jahangirnagar University. He has 21 years’ colourful working experiences in different academic and research institutions in Bangladesh, Malaysia and Japan. Before joining to State University of Bangladesh, he worked as Visiting Research Fellow and Principal Investigator of two High Impact Research Projects in the University of Malaya. He also worked as the Head of Pharmacology Department, Coordinator for Post-Graduate Program, Chairman of Animal Ethics Committee, and Head of Animal Experimental Unit of Lincoln University College Malaysia; Head of Pharmacy Department in Daffodil International University (Bangladesh) and also worked in national and multinational Pharmaceutical companies in Bangladesh. He is a Registered “A” grade Pharmacist in Bangladesh and GCP certified Clinical Researcher endorsed by the DG Health of Malaysia. Prof. Moklesur so far has supervised 1 Post-Doctoral, 3 PhD, 90 postgraduate and 69 undergraduate students’ research projects. He has already completed 82 Research Projects in Pharmaceutical and Health Sciences and published 98 scientific articles in peer reviewed international journals including high impact factor journals published by Elsevier, Wiley-Blackwell, Frontiers, Taylor & Francis, Informa Healthcare, Springer, BioMed Central, and Wolters Kluwer - Medknow Publications. He is serving as the Editor-in-Chief, Journal of Pharmacology and Toxicology; Editorial Board Member of several international journals including Frontiers in Bioscience-Landmark (Impact Factor: 2.747), Frontiers in Pharmacology (Impact Factor: 4.225), Pharmaceutical Sciences (Web of Science, Scopus, PubMed), Pakistan Journal of Biological Sciences (Scopus, PubMed), International Journal of Pharmacology (ISI, Scopus, IF: 0.692), Medicine & Health (Web of Science), Int. Journal of Pharmacy and Pharm. Sciences (Scopus). He is also serving as a Reviewer of a number of Peer Reviewed International journals. So far he has has achieved 811 citations, H-index 18, i-10-index: 25, and Researchgate (RG) score: 29.72. His research interests include diabetes & antidiabetic medicaments, immunomodulating agents, cancer & anticancer agents, lipid lowering/antiobesity agents, Prophetic medicines, phytomedicines/herbal medicines, functional foods & nutraceuticals, antibiotic resistance, rational use of drugs, substandard/adulterated/counterfeit drugs, impact of food adulteration on public health. His research team is currently focusing on the discovery and development of alternative medicines (herbal/phytomedicines, nutraceuticals, functional foods) for the treatment/management of diabetes, cancer, immunity, obesity/hyperlipidemia, fatty liver and aphrodisiac problems with minimum or without side-effects. Prof. Moklesur attended a number of international conferences, workshops and scientific seminars as invited speaker and oral presenter, and bagged few awards as the best speaker. In the year 2015, he delivered his scientific presentation on his discovery of antidiabetic medications in Harvard University, USA, which was highly appreciated by the high level scientists from Harvard Medical School, National Institute of Health (USA), and scientist and academicians from different universities of USA and other countries. He obtained several research grants such as Project Director, Antidiabetic special Research Grant, Ministry of Science and Technology (Bangladesh) 2019; Project Director of research grant for the development of Immunobooster against COVID-19 infections, Ministry of Science and Technology (Bangladesh) 2020; Project Leader, BKP Research Grant, University of Malaya in 2014; Project leader of High Impact Research Grant, University of Malaya Allocated Research Project; Principal Investigator, MABL Chair for Prophetic Medicine, Taiba University (Saudi Arabia); and Several Contract Research Projects from Innoscience Research Sdn. Bhd (Malaysia). Prof. Moklesur is currently mentoring a number of research projects of PhD, Post-Graduate and Undergraduate students and also involved with 20 different research projects in different academic and research institutions in Malaysia, USA, Australia, Japan, Saudi Arabia, and Bangladesh. He has obtained three PATENTs for the discovery and development of medications for diabetes, hyperlipidemia and immune-disorders. He is a member of several professional bodies, such as Academic Society of Functional Foods and Bioactive Compounds - USA, Malaysian Pharmaceutical Society, Pharmaceutical Society of Japan, Bangladesh Pharmaceutical Society, American Society of Microbiology, and Bangladesh Pharmacy Graduates’ Association. As an acknowledgement of his outstanding contribution for research and innovation, his biography has been published in the Marquis “Who’s Who in the World 2016” (33rd Edition, VIP Number: 37008993)”.

Publications

  1. Alam S, Sarker MMR*, Afrin S, Richi FT, Zhao C, Zhou J-R, Mohamed IN. Traditional herbal medicines, bioactive compounds, and plant products against COVID-19: Update on clinical trials and mechanisms of action. Frontiers in Pharmacology 2021; 12:671498. doi: 10.3389/fphar.2021.671498 (ISI Impact Factor: 5.810).
  2. Anmol RJ, Marium S, Hiew FT, Han WC, Kwan LK, Wong AKY, Sarker MMR*, Chan SY, Kifli N, Ming LC. Phytochemical and Therapeutic Potential of Citrus grandis (L.) Osbeck: A Review. Journal of Evidence-Based Integrative Medicine (PubMed/Medline, Scopus) - Accepted.
  3. Alam S, Kamal TB, Sarker MMR*, Zhou J-R, Rahman SMA, Mohamed IN. Therapeutic effectiveness and safety of repurposing drugs for the treatment of COVID-19: Position standing in 2021. Frontiers in Pharmacology 2021; 12:659577. doi: 10.3389/fphar.2021.659577 (ISI Impact Factor: 5.810).
  4. Alam S, Rashid MA, Sarker MMR, Emon NU, Arman M, Mohamed IN, Haque MR. Antidiarrheal, antimicrobial and antioxidant potentials of methanol extract of Colocasia gigantea Hook. f. leaves: evidenced from in vivo and in vitro studies along with computer-aided approaches. BMC Complementary Medicine and Therapy 2021; 21: 119. doi: 10.1186/s12906-021-03290-6 (ISI Impact Factor: 3.659).
  5. Ang LP, Ng PW, Lean YL, Kotra V, Kifli N, Goh HP, Lee KS, Sarker MMR, Al-Worafi YM, Ming LC. Herbal Products Containing Aristolochic Acids: A Call to Revisit the Context of Safety. Journal of Herbal Medicine 2021. doi: 10.1016/j.hermed.2021.100447 (ISI Impact Factor: 3.032).
  6. Sarker MMR*, Khan F, Mohamed IN. Therapeutic Potential of Carica papaya L. Leaves for the Treatment of Dengue Fever: A Review Based on Scientific Evidences. Frontiers in Pharmacology 2021; 12: 610912. doi: 10.3389/fphar.2021.610912 (ISI Impact Factor: 5.810).
  7. Sarker MMR*. Evaluation of Red and Green Colored Bell peppers for the Production of Polyclonal IgM and IgG Antibodies in Murine Spleen Cells. Bangladesh Pharmaceutical Journal 2021; 24(1): 45-53. Doi:10.3329/bpj.v24i1.51635.
  8. Israfil SMH, Sarker MMR*, Rashid PT, Talukder AA, Kawsar KA, Khan F, Akhter S, La PC, Ming LC, Mohamed IN. Clinical characteristics and diagnostic challenges of COVID-19 : An update from the global perspective. Frontiers in Public Health 2021; 8:567395. doi: 10.3389/fpubh.2020.567395 (ISI Impact Factor: 3.709).
  9. Ibrahim NI, Tadj NBMI, Sarker MMR, Mohamed IN. The Potential Mechanisms of the Neuroprotective Actions of Oil Palm Phenolics: Implications for Neurodegenerative Diseases. Molecules 2020; 25:5159. doi:10.3390/molecules25215159 (ISI Impact Factor: 4.411).
  10. Munira S, Nesa L, Islam MS, Begum Y, Rashid MA, Sarker MMR, Ahmed T. Antidiabetic activity of Neolamarckia cadamba (Roxb.) Bosser flower extract in alloxan-induced diabetic rats. Clinical Phytoscience 2020; 6:33 (Springer, USA). doi.org/10.1186/s40816-020-00183-y.
  11. Sarker MMR*, Soma MA. Updates on Clinical Study Reports of Phytotherapy in the Management of Type 2 Diabetes Mellitus. In: Eddouks M, Editor. Phytotherapy in the Management of Diabetes and Hypertension. Vol. 4. Sharjah, UAE: Bentham Science Publishers; 2020. p. 1-60 (Book chapter)
  12. Izadi E, Ming LC, Patel R, Zaid STR, Sarker MMR, Rao VM. Levofloxacin: Insights Into Antibiotic Resistance and Product Quality. Frontiers in Pharmacology 2019; 10: 881. doi: 10.3389/fphar.2019.00881 (ISI Impact Factor: 5.810).
  13. Kamarudin MNA, Sarker MMR, Zhou J-R, Parhar I. Metformin in colorectal cancer: Molecular mechanism, preclinical and clinical aspects. Journal of Experimental & Clinical Cancer Research 2019; 38:491. doi.org/10.1186/s13046-019-1495-2 (ISI Impact Factor: 11.161).
  14. Khan F, Sarker MMR*, Ming LC, Mohamed IN, Zhao C, Sheikh BY, Tsong HF, Rashid MA. Comprehensive Review on Phytochemicals, Pharmacological and Clinical Potentials of Gymnema sylvestre. Frontiers in Pharmacology 2019; 10: 1223. doi: 10.3389/fphar.2019.01223 (ISI Impact Factor: 5.810).
  15. Chen Y, Liu D, Wang D, Lai S, Zhong R, Liu Y, Yang C, Liu B, Sarker MMR, Zhao C. Hypoglycemic activity and gut microbiota regulation of a novel polysaccharide from Grifola frondosa in type 2 diabetic mice. Food and Chemical Toxicity 2019; 126: 295-302. doi: 10.1016/j.fct.2019.02.034 (ISI Impact Factor: 6.023).
  16. Jahan E, Kassab YW, Fen NC, Ming LC, Yen WY, Hameed MA, Hong YH, Sarker MMR. Self-care and self-management among type 2 diabetes mellitus patients- A focused review. Frontiers in Endocrinology 2018; 9:489 doi: 10.3389/fendo.2018.00489 (ISI Impact Factor: 5.555).
  17. Chen Y, Liu Y, Sarker MMR, Yan X, Yang C, Zhao L, Lv X, Liu B, Zhao C. Structural characterization and antidiabetic potential of a novel heteropolysaccharide from Grifola frondosa via IRS1/PI3K-JNK signaling pathways. Carbohydrate Polymers 2018; 198: 452-461. doi.org/10.1016/j.carbpol.2018.06.077 (ISI Impact Factor: 9.381).
  18. Shajib MS, Rashid RB, Long MC, Sarker MMR, Islam S, Nahar L, Sarker SD, Datta BK, Rashid MA. Polymethoxyflavones from Nicotiana plumbaginifolia (Solanaceae) exert antinociceptive and neuropharmacological effects in mice. Frontiers in Pharmacology 2018; 9:85. doi:10.3389/fphar.2018.00085 (ISI Impact Factor: 5.810).
  19. Nesa MS, Karim SMS, Api K, Sarker MMR, Islam MM, Kabir A, Sarker MK, Nahar K, Asaduzzaman M, Munir MS. Screening of Baccaurea ramiflora(Lour.) extracts for cytotoxic, analgesic, anti-inflammatory, neuropharmacological and antidiarrheal activities. BMC Complementary Medicine and Therapeutics 2018; 18:35. doi: 10.1186/s12906-018-2100-5 (ISI Impact Factor: 3.659).
  20. Ali A, Leee KS, Bukhshb A, Al-Worafic YM, Sarker MMR, Ming CM, Khan TM. Outbreak of vaccine-preventable diseases in Muslim majority countries. Journal of Infection and Public Health 2018; 11: 153-155 (Elsevier, ScienceDirect). DOI: 10.1016/j.jiph.2017.09.007 (ISI Impact Factor: 3.718).
  21. Al-Worafi YM, Alseragi WM, Seng LK, Kassab YW, Yeoh SF, Ming LC, Sarker MMR, Husain KA. Dispensing Errors in Community Pharmacies: A Prospective Study in Sana'a, Yemen. Archieves of Pharmacy Practice 2018; 9(4): 1-3.
  22. Sheikh FICS BY, Sarker MMR*, Kamarudin MNA and Ismail A. Prophetic Medicine as potential functional food elements in the intervention of cancer: A review. Biomedicine and Pharmacotherapy 2017; 95:614-648 (Elsevier, ScienceDirect). DOI: 10.1016/j.biopha.2017.08.043 (ISI Impact Factor: 6.529).
  23. Hossain G, Uddin SM, Islam A, Saw A, Lestrel PE, Banna H, Sarker MMR. Factors Associated With HIV Testing Behaviors among Female Sex Workers in Rajshahi City, Bangladesh. Journal of Life Sciences 2017; 9(2): 104-110 (Taylor & Francis, UK). DOI: 10.1080/09751270.2017.1424512.
  24. Sheikh BY, Sarker MMR*, Kamarudin MNA, Mohan GMD. Antiproliferative and apoptosis inducing effects of citral via p53 and ROS-induced mitochondrial-mediated apoptosis in human colorectal HCT116 and HT29 cell lines. Biomedicine and Pharmacotherapy 2017; 96:834-846 (Elsevier, ScienceDirect). DOI: 10.1016/j.biopha.2017.10.038 (ISI Impact Factor: 6.529).
  25. Jesuraj AV, Sarker MMR*, Long CM, Praya MJ, and Kumar MR. Enhancement of the production of L-Glutaminase, an anticancer enzyme, from Aeromonas veronii by adaptive and induced mutation techniques. Plos One 2017 12(8):e0181745;DOI: 10.1371/journal.pone.0181745 (ISI Impact Factor: 3.240).
  26. Sharma D, Patel RP, Zaidi STR, Sarker MMR, Lean QY, Ming LC. Interplay of quality of ciprofloxacin and antibiotic resistance in developing countries. Frontiers in Pharmacology 2017;8:546; DOI: 10.3389/fphar.2017.00546 (ISI Impact Factor: 5.810).
  27. Rouhi SZT, Sarker MMR*, Rahmat A, Alkahtani SA, Othman F. The effect of pomegranate fresh juice versus pomegranate seed powder on metabolic indices, lipid profile, inflammatory biomarkers, and the histopathology of pancreatic Islets of Langerhans in streptozotocin-nicotinamide induced type 2 diabetic Sprague-Dawley rats. BMC Complementary Medicine and Therapeutics 2017; 17: 156 (Nature-Springer); DOI 10.1186/s12906-017-1667-6 (ISI Impact Factor: 3.659).
  28. Kamarudin NMA, Sarker MMR*, Kadir HA, Ming LC. Ethnopharmacological uses, phytochemistry, biological activities and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review. Journal of Ethnopharmacology 2017; 206: 245-266 (Elsevier, Science Direct); DOI: 10.1016/j.jep.2017.05.007 (ISI Impact Factor: 4.360).
  29. Ullah K, Sarker MMR, Khan MS, Mustapha MS, Ullah MK. Anti-diabetic Activity of Compound “2-[(trimethylsilyl) oxy] - Methyl Ester (cas) Methyl-o-trim-ethyl-silylsalicylate” Isolated from Pericampylus glaucus (Lam) Merr in STZ-Induced Diabetic Rats. Journal of Basic and Clinical Pharmacy 2017; 8(2): 68-73 (PUBMED, SCOPUS cited).
  30. Kifayatullah M, Mustapha MS, Sarker MMR, Izharullah and Amin M. Effect of compounds identified in active fraction of P. glaucus against blood glucose and lipid profile in streptozotocin-induced diabetic rats. Egyptian Pharmaceutical Journal 2017; 16(1): 8-15 (Walters Kluwer-Medknow, PUBMED, SCOPUS cited); DOI: 10.4103/1687-4315.205823.
  31. Kifayatullah M, Mustapha MS, Sarker MMR, Kaleemullah, Amin M and Ali F. Possible role of a compound identified from Pericampylus glaucus plant in controlling blood glucose in experimental animals. Egyptian Pharmaceutical Journal 2017; 16(1): 37-42 (Walters Kluwer-Medknow, PUBMED, SCOPUS cited); DOI: 10.4103/1687-4315.205824.
  32. Das SK, Mustapha MS, Sengupta P, Sarker MMR. An experimental evaluation of adaptogenic potential of standardized Epipremnum aureum leaf extract. Journal of Pharmacy and Bioallied Sciences 2017; 9(2):88-93. (Walters Kluwer-Medknow, PUBMED, SCOPUS cited); DOI: 10.4103/0975-7406.183227.
  33. Kifayatullah M, Sarker MMR*, Mustapha MS. Phytochemical investigation of ethanolic extract of Pericampylus glaucus leaves from Malaysia by GC-MS analytical technique. International Journal of PharmTech Research 2017; 9(12):410-416 (SCOPUS cited).
  34. Kifayatullah M, Mustapha MS, Sarker MMR, Das SK and Sengupta P. Effect of ethanolic extract of Pericampylus glaucus (Lam) Merr on biochemical parameters in high fats diets Sprague-Dawley rats. Pakistan Journal of Pharmaceutical Research 2017; 3(1):1-8; DOI: 10.22200/pjpr.201711-8.
  35. Krayemi AAA and Sarker MMR. Evaluation of the Anti-Diabetic Activity of a Novel Formulation of Functional Foods in Streptozotocin- Induced Balb/c Diabetic Mice Model. International Journal of Science and Research 2017; 6(2):2088-2096; DOI: 10.21275/ART20171327.
  36. Elaswed EEE and Sarker MMR. Evaluation of Antidiabetic Potential of A Novel Formulation from Prophetic Medicine in Streptozotocin-Induced Diabetic Balb/C Mice. International Journal of Science and Research 2017; 6(3):857-865; DOI: 10.21275/ART20171623.
  37. Salem HA and Sarker MMR. Evaluation of A Novel Formulation from Functional Foods for Hypoglycemic and Weight Loss Activities in High-Fat Balb/C Mice. International Journal of Science and Research 2017; 6(2):1020-1027; DOI: 10.21275/ART2017902.
  38. Das SK, Mustapha MS, Sengupta P, Sarker MMR. An experimental evaluation of adaptogenic potential of standardized Epipremnum aureum leaf extract. Journal of Pharmacy and Bioallied Sciences 2017; 9 (2): 88–93 (PUBMED and Scopus cited); doi: 10.4103/0975-7406.183227.
  39. Sarker MMR*, Ming LC, Sarker MZI, and Choudhuri MSK. Immunopotentiality of Ayurvedic polyherbal formulations "Saribadi" and "Anantamul Salsa" with augmentation of IgM production and lymphocytes proliferation: A preliminary study. Asian Pacific Journal of Tropical Biomedicine 2016; 6(7): 568-573 (Elsevier, PUBMED); DOI: 10.1016/j.apjtb.2016.05.004 (ISI Impact Factor: 1.545).
  40. Rahim NHA, Long MC, Al Worafi YMA, Sarker MMR. A regulatory review for products containing Glutathione. Archives of Pharmacy Practice 2016;7(1): S57-S60 (SCOPUS cited); DOI:10.4103/2045-080X.183029.
  41. Sarker MMR*, Rashid MS, Raju AA, Rana M, Karim MFB, Howlader NMAN and Akter R. Evaluation of the Pharmaceutical Quality of Different Brands of Ranitidine Tablets Manufactured and Marketed in Bangladesh. Journal of Applied Pharmaceutical Science 2016; 6(1): 055-061 (SCOPUS cited); DOI: 10.7324/JAPS.2016.60109.
  42. Saleh MS, Shaharuddin S, Sarker MMR, Long CM. Safety and efficacy of Labisia pumila containing products. Archives of Pharmacy Practice 2016; 7(5): 53-56 (SCOPUS cited); DOI:10.4103/2045-080X.183028.
  43. Shah MA, Sarker MMR, Gousuddin M. Toxicity Study of Brassica oleracea Var. Italica Extracts in Sprague Dawley (SD) Rats. International Journal of Pharmacognosy and Phytochemical Research 2016; 8(5): 735-741 (SCOPUS cited).
  44. Shah MA, Sarker MMR, Gousuddin M. Antidiabetic potential of Brassica oleracea var. Italica in type 2 diabetic sprague dawley (SD) rats. International Journal of Pharmacognosy and Phytochemical Research 2016; 8(3): 462-469 (SCOPUS cited).
  45. Jesuraj AV, Ravikumar M, Sarker MMR, and Praya M. Apoptotic Induction on HT29 cells by immobilized L-glutaminase. Pharmanest 6(4): 2960-2963 (2015).
  46. Das SK, Sengupta P, Mustapha S, Das A, Sarker MMR, Kifayatullah M. Toxicological investigation of ethanolic extract of Epipremnum aureum in rodents. Journal of Applied Pharmaceutical Science 5 (2), 057-061 (2015) (SCOPUS cited); DOI: 10.7324/JAPS.2015.58.S9.
  47. Rajamanickam G, Selvaraj S, Selvaraj J, Rajendran T, and Sarker MMR. In vitro anthelmintic and antimicrobial activity of novel series of quinoxaline- 2, 3-dione -6-sulphonyl benzimidazole(s). Journal of Chemical and Pharmaceutical Sciences 8 (4), 656-660 (2015).
  48. Sarker MMR*, Zihad MATR, Islam M, Nahar M, Islam MM, Imam H, Ghosh A, Mustapha MS, and Ismail NE. Antihyperglycemic, insulin-sensitivity and anti-hyperlipidemic potential of Ganoderma lucidum, a dietary mushroom, on alloxan- and glucocorticoid-induced diabetic Long-Evans rats. Functional Foods in Health and Diseases 5 (12), 450-466 (2015); DOI: 10.31989/ffhd.v5i12.220 (ISI Impact Factor: 1.88).
  49. Kifayatullah M, Mustapha MS, Senguptha P, Sarker MMR, Das A and Das SK. Evaluation of the acute and sub-acute toxicity of the ethanolic extract of Pericampylus glaucus (Lam.) in Balb/c mice. Journal of Acute Disease 4(4), 303-308 (2015) (Elsevier, Science Direct, SCOPUS, Web of Science cited); DOI: 10.1016/j.joad.2015.06.010.
  50. Hasan MA, Hasan MR, Uddin MJ, Begum G, Abdullah N, Sarker MMR, Chowdhury MMH and Choudhuri MSK. Preclinical blood chemistry safety profile studies of “Rohitakarista” on the kidney function after chronic administration to male sprague-dawley rats. International Journal of Pharmacy 5(2), 367-373 (2015).
  51. Sikder MM, Hasan MR, Lopa SS, Abedin N, Uddin MJ, Sarker MMR, Chowdhury MMH and Choudhuri MSK. Toxicological studies of an Ayurvedic medicine Karpur Ras used in diarrhoea. International Journal of Pharmacy 5(2), 472-477 (2015).
  52. Easmin MS, Sarker MZI, Sahena F, Shamsudin SH, Yunus K, Uddin MS, Sarker MMR, Akanda MJI, Hossain MS and Khalil MPSA. Bioactive compounds and advanced processing technology: Phaleria macrocarpa (sheff.) Boerl, a review. Journal of Chemical Technology & Biotechnology 90(6), 981-991 (2015) (Willey-Black Well, PUBMED); DOI 10.1002/jctb.4603 (ISI Impact Factor: 3.174).
  53. Nahar K, Hasan MR, Chowdhury SK, Chakma P, Begum G, Abdullah N, Sarker MMR and Choudhuri MSK. Preclinical blood chemistry safety profile studies of “Basanta Kusumakar Ras” after chronic administration to male Sprague-Dawley rats. International Journal of Pharmacy 5 (1), 146-152 (2015).
  54. Karim MFB, Imam H, Sarker MMR, Uddin N, Hasan N, Paul N and Haque T. Free Radical Scavenging, Anti-Diarrhoeal and Anthelmintic Activity of Pistia stratiotes L. extract and its Phytochemical Analysis. Pakistan Journal of Pharmaceutical Sciences 28 (3) 915-920 (2015) (ISI Impact Factor: 0.684).
  55. Kazemipoor M, Cordell GA, Sarker MMR, Jasimah CW, Hajifaraji M and Kiat PE. Alternative Treatments for Weight Loss: Safety/Risks and Effectiveness of Anti-obesity Medicinal Plants. International Journal of Food Properties 18(9), 1942-1963 (2015) (PUBMED); DOI: 10.1080/10942912.2014.933350 (ISI Impact Factor: 2.727).
  56. Sarker MMR*, Islam KN, Huri HZ, Rahman M, Imam H, Hosen MB, Mohammad N and Sarker MZI. Studies of the impact of occupational exposure on pharmaceutical workers to the development of antimicrobial drug resistance. Journal of Occupational Health 56 (4), 260-270 (2014) (PUBMED); DOI: 10.1539/joh.14-0012-OA (ISI Impact Factor: 2.708).
  57. Sarker MMR* and Zhong M. Keyhole Limpet Hemocyanin augmented the killing activity, cytokine production and proliferation of NK cells, and inhibited the proliferation of Meth A carcoma cells in vitro. Indian Journal of Pharmacology 46(1), 28-33 (2014) (PUBMED); DOI: 10.4103/0253-7613.125164 (ISI Impact Factor: 1.200).
  58. Sarker MMR*, Imam H, Ahmed S and Choudhuri MSK. In vitro assessment of Prasarani Sandhan, a traditional polyherbal Ayurvedic medicine, for immunostimulating activity splenic cells of BALB/c mice. International Journal of Pharmacy and Pharmaceutical Sciences 6 (9), 13-15 (2014) (SCOPUS cited).
  59. Sarker MMR*. Selection of proper antidiabetic drugs for diabetic patients with cardiovascular diseases: Why so important? Pharmaceutical Sciences 20 (2), 1-2 (2014) (SCOPUS, Web of Science indexed).
  60. Imam H, Chowdhury A, Mahbub NU, Hossain A, Karim MFB, Uddin MB and Sarker MMR. Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study. Journal of Diabetes & Metabolic Disorders 13:54 (2014) (BioMedCentral, PUBMED, SCOPUS cited) (ISI Impact Factor: 2.030).
  61. Sarker MMR*. Adulteration of herbal medicines and dietary supplements with undeclared synthetic drugs: dangerous for human health. International Journal of Pharmacy and Pharmaceutical Sciences 6(4), 1-2 (2014) (SCOPUS cited).
  62. Sarker MMR*. Therapeutic efficacy and safety of traditional Ayurvedic medicines: Demands for extensive research and publications (Editorial). Journal of Homeopathy and Ayurvedic Medicines 3 (3), 2014; DOI: 10.4172/2167-1206.1000e113.
  63. Karim MFB, Imam H, Uddin N, Paul N, Haque T, Sarker MMR and Rana MS. Phytochemical and Pharmacological Investigations of Pistia Strationtes L. International Journal of Innovative Pharmaceutical Sciences and Research 2(3), 640-652 (2014).
  64. Imam H, Mahbub NU, Khan MF, Hana HK and Sarker MMR. Alpha Amylase Enzyme Inhibitory and Anti-inflammatory Effect of Lawsonia inermis. Pakistan Journal of Biological Sciences 16 (23), 1796-1800 (2013) (SCOPUS, Web of Science, PubMed indexed); DOI: 10.3923/pjbs.2013.1796.1800.
  65. Sarker MMR* and Gohda E. Promotion of anti-keyhole limpet hemocyanin IgM and IgG antibody productions in vitro by red bell pepper extract. Journal of Functional Foods 5(4), 1918-1926 (2013) (Elsevier, Science Direct, PUBMED); DOI: 10.1016/j.jff.2013.09.013 (ISI Impact Factor: 4.451)
  66. Sarker MMR*, Nahar S, Shahriar M, Seraj S and Choudhuri MSK. Preliminary study of the immunostimulating activity of an ayruvedic preparation, Kanakasava, on the splenic cells of BALB/c mice in vitro. Pharmaceutical Biology 50(11), 1467-1472 (2012) (Taylor & Francis, PUBMED); DOI: 10.3109/13880209.2012.681329 (ISI Impact Factor: 3.503).
  67. Sarker MMR*. Induction of humoral immunity through the enhancement of IgM production in murine splenic cells by ethanolic extract of seed of Piper nigrum L. Journal of Scientific Research 4 (3), 65-69 (2012); DOI: 10.3329/jsr.v4i3.10485.
  68. Sarker MMR*, Nimmi I and Kawsar M H. Preliminary screening of six popular fruits of Bangladesh for in vitro IgM production and proliferation of splenocytes. Bangladesh Pharmaceutical Journal 15 (1), 31-37 (2012).
  69. Rashid MH, Gafur MA, Sarker MMR and Karim N. A Spinasteryl Glycoside from Ipomoea turpethum L. Herb (Stem) Growing in Bangladesh. Journal of Bangladesh Academy of Science 36 (1), 13-17 (2012).
  70. Sarker MMR*, Choudhuri MSK and Zhong, M. Effect of Chandanasav, an Ayurvedic formulation, on mice whole splenocytes for the production of polyclonal IgM and proliferation of cells-A preliminary study. International Journal of Pharmaceutical Sciences and Research 3 (5), 1294-1299 (2012) (SCOPUS cited); 10.13040/IJPSR.0975-8232.3(5).1294-99.
  71. Sarker MMR*, Mazumder MEH and Rashid MH. In vitro Enhancement of Polyclonal IgM Production by Ethanolic Extract of Nigella sativa L. seeds in whole Spleen Cells of Female BALB/c Mice. Bangladesh Pharmaceutical Journal 14 (1), 73-77 (2011).
  72. Goto T, Sarker MMR, Zhong M, Tanaka S and Gohda E. Enhancement of IgM Production in B Cells by the Extract of Red Bell Pepper. Journal of Health Science 56(3), 304-309 (2010) (ISI Impact Factor: 0.81).
  73. Yasmin H, Kaisar MA, Sarker MMR, Rahman MS and Rashid MA. Preliminary anti-bacterial activity of some indigenous plants of Bangladesh. Dhaka University Journal of Pharmaceutical Sciences 8 (1), 61-65 (2009).
  74. Sarker MMR and Ghani A. Cultural and health management practices of the Garo community of Bangladesh: A case study of the Garos of greater Mymensingh district. Stamford Journal of Pharmaceutical Sciences 1 (1&2), 29-37 (2008) (SCOPUS cited).
  75. Sarker MMR*, Kawsar MH and Ghani A. Health management practices and influence of socio-cultural habits on the health management systems of an ethnic group of people in Bangladesh. University of Science and Technology Annual 13 (1), 19-36 (2007).
  76. Sarker MMR*, Hossain MA, Rafiquzzaman M and Hoque MM. Chemical (HPLC) analysis and bioassay studies on the quality of some brands of Ciprofloxacin tablets marketed in Bangladesh. University of Science and Technology Annual 12 (1), 24-37 (2006).

Awards & Achievements